Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Full results from the Phase 2 REGEN-007 study of rilparencel were recently presented as a late-breaking clinical trial at the American Society of Nephrology (ASN) Kidney Week 2025More than half of the...
-
Late-Stage Neuroinflammation Platform Advancing Global Registrational Programs in Guillain-Barré Syndrome (GBS) and Geographic Atrophy (GA) Current Tanruprubart GBS Dossier On Track for MAA Filing in...
-
NUMBER OF SHARES COMPOSING CURRENT SHARE CAPITAL AND TOTAL NUMBER OF VOTING RIGHTS AS OF 31 OCTOBER 2025Regulated Information Paris, 10 November 2025 Information about the total number of voting...
-
NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET NOMBRE TOTAL DE DROITS DE VOTE AU 31 OCTOBRE 2025 Information réglementée Paris, le 10 novembre 2025 Informations relatives au nombre total de droits de...
-
Company’s transformative agentic AI SOC platform helps customers thrive in a rapidly evolving IT landscape DALLAS, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Conifers.ai, the agentic AI SOC platform...
-
Skyhawk Security, the leader in Purple Team-Powered Preemptive Cloud Security, announced today that is has been named in CRN's® Stellar Startups list.
-
SANTA CLARA, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco” or the “Company”), today announced that it has reached a settlement resolving all matters related...
-
Schaumburg, IL, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery Association (ASDSA), an organization dedicated to advocating on behalf of dermatologic surgeons and...
-
New York, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an update note on MAIA ...
-
Event being held today at 8:00 a.m. ET in New York City features presentations from Ovarian Cancer Key Opinion Leaders, Clinicians, Statistical Experts, and IMUNON executives Investors, stakeholders,...